Burlington-based endovascular medical device firm CorNova Inc. has pulled in $2.5 million of a planned $6 million equity financing, according to a regulatory filing.
The company develops a set of balloon catheters designed to help eliminate cases of stent restenosis, or thrombosis, by helping with stent selection and optimizing the process of implanting the stent, explained Eric Ryan, the company CEO, in an earlier Mass High Tech report. Its FiberHalo catheters carry a hair-thin fiber wire that provides blood vessel measurement from inside the balloon itself to assist in stent procedures, without a corresponding increase in time, risk or cost. It uses fiber optics to make measurements that allow physicians to tell if a stent is adequately deployed.
Founded in 2003, CorNova grew its workforce in February to 25 employees, including a new chief financial officer and new senior scientist this year.
Latest from Today's Medical Developments
- NextDent 300 MultiJet printer delivers a “Coming of Age for Digital Dentistry” at Evolution Dental Solutions
- Get recognized for bringing manufacturing back to North America
- Adaptive Coolant Flow improves energy efficiency
- VOLTAS opens coworking space for medical device manufacturers
- MEMS accelerometer for medical implants, wearables
- The compact, complex capabilities of photochemical etching
- Moticont introduces compact, linear voice coil motor
- Manufacturing technology orders reach record high in December 2025
